Seeking Alpha

Miles P. Jennings'  Instablog

Miles P. Jennings
Send Message
Interested in patented and proprietary products as well as deep value. Recently released a novel entitled Changing Hands in Chinatown.
My blog:
View Miles P. Jennings' Instablogs on:
  • Chembio's (CEMI) Partnership With Integrated BioTherapeutics For Developing An Ebola Point-Of-Care Test Kit

    On October 27th Chembio Diagnostics (NASDAQ:CEMI) announced an exclusive partnership with Integrated BioTherapeutics (IBT) to develop a Point-of-Care diagnostic test for Ebola and Febrile Illness.

    A few key points regarding the partners:

    • Dr. M. Javad Aman is President and Chief Scientific Officer of IBT. It appears that his U.S. Patent Application #US20100143409A1 published on June 10, 2010 regarding "Generation of virus-like particles and use as panfilovirus vaccines" contains important novel scientific methods that might lead to developing a successful Ebola POC test kit.
    • Chembio's Dual Path Platform has been approved by the FDA and patented by the USPTO. Recently, the FDA granted Chembio's CLIA waiver request for the Dual Path Platform for HIV POC test.
    • In the Seeking Alpha's transcript of Chembio's recent Q3 2014 conference call, John J. Sperzel, CEO, stated "While it may appear we were late in announcing our plan to develop a point-of-care test for Ebola, we chose to first focus on securing access to critical Ebola antibodies, hence the partnership with IBT, which is exclusive for point-of-care product development. In addition, we felt it was important to test IBT's antibodies on the DPP platform. Based on our early findings, we believe it is possible to develop a standalone DPP Ebola assay." (my emphasis) Having exclusivity regarding IBT's proprietary antibodies---i.e., for point-of-care products---will allow Chembio to carefully plan its introduction of POC-related tests.
    • IBT is a privately held company. Chembio (CEMI) has 9.6 million shares and closed today at 4.39, a market cap of $42 million.
    Nov 14 12:12 AM | Link | Comment!
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.